Midi Health, a virtual care clinic for women 35 and older, has announced the launch of a Survivorship Program. This program aims to provide menopause care for breast cancer survivors and women at high risk for breast cancer. The program was developed and is led by Dr. Mindy Goldman, a Clinical Professor in the Department of OB/GYN at UC San Francisco and…
Researchers at the University of Oxford have received funding from Cancer Research UK to develop OvarianVax, potentially the world’s first vaccine to prevent ovarian cancer. The team has been awarded up to £600,000 over the next three years to support laboratory research into the vaccine. The vaccine aims to teach the immune system to recognize and attack the earliest stages of ovarian…
Cartherics, an Australian biotech company developing immune cell therapies, has announced the successful completion of an oversubscribed private financing round, raising over AU$15 million. This funding will primarily support the clinical trial of CTH-401, the company’s lead cell therapy for ovarian cancer, and expand its pipeline to include other diseases. Based in Melbourne, Cartherics focuses on developing cell-based immunotherapies for cancer treatment.…
Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved Kisqali (ribociclib) for a new indication in early breast cancer. This approval marks a significant development in breast cancer treatment, particularly for women with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) early breast cancer. The FDA has approved Kisqali in combination with an aromatase inhibitor for adjuvant…
DeepLook Medical, the company behind DL Precise, the first FDA-cleared AI technology designed to detect cancer in dense breast tissue, has announced the successful first close of its Series A funding round. The round was led by Xcellerant Ventures, with additional support from OKG Capital. This funding milestone will support the company’s continued growth and its efforts to enhance cancer detection and…
Luminate, a startup developing wearable devices to improve cancer treatment, has raised $15 million in a Series A funding round to accelerate its innovation and bring cancer care into patients’ homes. Led by Artis Ventures, with participation from Metaplanet, Lachy Groom, 8VC, SciFounders, and Faber, this latest investment will enable Luminate to expand its U.S. presence and move closer to FDA approval…
Melodi Health, a medical device company based in Minneapolis, announced two significant milestones last week. The company successfully closed a $10.75 million oversubscribed Series A funding round and launched the “ARIA” investigational device exemption (IDE) trial, designed to improve outcomes for women undergoing breast reconstruction following mastectomy. The funds raised will support ongoing clinical activities and further product development. Melodi Health, founded…
Cairn Surgical, a medtech company focused on enhancing the precision of breast cancer surgeries, has successfully closed $4.5 million in Series A2 financing led by Morningside Ventures. The newly acquired funds will be directed towards completing the pivotal U.S. trial of Cairn Surgical’s Breast Cancer Locator (BCL™) System, a novel technology designed to significantly enhance the accuracy of breast-conserving surgeries, commonly known…
